e-learning
resources
Glasgow 2004
Monday 06.09.2004
Method aspects and risk environments of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GOLD classification of COPD and incident lung cancer: findings from a cohort study
D. M. Mannino, F. Holguin, A. Baron, D. E. Doherty, A. S. Buist (Atlanta, Lexington, Portland, United States Of America)
Source:
Annual Congress 2004 - Method aspects and risk environments of respiratory diseases
Session:
Method aspects and risk environments of respiratory diseases
Session type:
Poster Discussion
Number:
1753
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. M. Mannino, F. Holguin, A. Baron, D. E. Doherty, A. S. Buist (Atlanta, Lexington, Portland, United States Of America). GOLD classification of COPD and incident lung cancer: findings from a cohort study. Eur Respir J 2004; 24: Suppl. 48, 1753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004
A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
GOLD classifications and mortality in COPD: The HUNT study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Emphysema, COPD and lung cancer screening. Update of an ongoing study
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Lung cancer in COPD
Source: Eur Respir Mon 2013; 59: 174-188
Year: 2013
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Spirometry and under-diagnosis of COPD in a lung cancer screening cohort
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Characteristics of COPD in never smokers: results from the international burden of obstructive lung disease (BOLD) study
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017
Lung cancer screening in COPD patients.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Clinical feature of elderly patients with lung cancer and COPD
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
A retrospective evaluation of lung function and exacerbations in COPD patients-RETRIEVE study.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Canadian prediction equation of spirometric lung function for caucasian adults 18-90 years: Results from the Canadian obstructive lung disease (COLD) study and the Canadian ECRHS study
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept